Dr. Paul R. Kunk, MD

  • Charlottesville, VA
  • Medical oncologist
NPI1750671756PAC ID0244467454
Medicare services, 2024
877
Medicare patients, 2024
199
Part D claims, 2024
529
Publications
17
Clinical trials
4
Practice address
1240 Lee St,, Charlottesville, VA 22903
Practice phone
Call (434) 243-4704
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Emily Couric Clinical Cancer Center

Mammography / Breast Imaging Center · Charlottesville, Virginia

See all 7 affiliations

Find Dr. Kunk's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Paul R. Kunk is a medical oncologist in Charlottesville, Virginia

Dr. Kunk practices at Emily Couric Clinical Cancer Center in Charlottesville, Virginia.

Dr. Kunk's NPI, 1750671756, was assigned on April 11, 2011. Dr. Kunk holds Virginia license 0101258510.

NPI and contact details
Medicare PAC ID
0244467454
NPI enumeration date
April 11, 2011
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(434) 243-4704
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
41
Medical school graduation
2011

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Paul R. Kunk practices at Emily Couric Clinical Cancer Center in Charlottesville, Virginia

Dr. Kunk's primary practice is Emily Couric Clinical Cancer Center, at 1240 Lee St,, Charlottesville, VA 22903. The practice phone is (434) 243-4704.

  • Emily Couric Clinical Cancer Center
    1240 Lee St,, Charlottesville, VA 22903Phone(434) 243-4704

Source: Dmand AI Affiliation Data

Dr. Paul R. Kunk is affiliated with 6 sites of care and 1 medical group

Dr. Kunk's primary practice is Emily Couric Clinical Cancer Center in Charlottesville, Virginia. Dr. Kunk is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Kunk to 3 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Kunk's employer is on file too: a breast imaging center.

See all 7 affiliations for Dr. Kunk

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Paul R. Kunk's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kunk practices, 6 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Emily Couric Clinical Cancer CenterAvailable with a free account
+5 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Kunk practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Paul R. Kunk is one of 99 medical oncologists in Virginia

Medical oncology is Dr. Kunk's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kunk is licensed in Virginia.

Specialties and state licenses

  • Medical oncology, VirginiaPrimaryLicense 0101258510 · taxonomy 207RX0202X

Medical oncologists near Dr. Kunk

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Paul R. Kunk billed Medicare for 877 services in 2024

CMS data shows 877 Medicare services from Dr. Kunk across 7 procedure codes in 2024, for 199 Medicare patients. Medicare paid $57,335 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024877
Medicare patients199
Paid by Medicare$57,335
Procedure codes7

Dr. Kunk's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 5642024: 5571%
Other services
2023: 02024: 320

Dr. Kunk compared with the Virginia median for medical oncologists, 2024

  • Dr. Kunk
  • Virginia median
Medicare services
877vs 56655% above
Medicare patients
199vs 22210% below
Part D claims
345vs 30314% above

Medians across 96 medical oncologists in Virginia with Dmand AI profiles that report each measure.

Dr. Kunk's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Kunk

Need commercial claims for Dr. Kunk?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kunk and other medical oncologists in Virginia.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Paul R. Kunk treated 199 Medicare patients in 2024, average age 73

CMS counts 199 Medicare patients who saw Dr. Kunk in 2024. The largest group is 65 to 74, with 107 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kunk's median patient age at 67, with 46% women.

Medicare patients, 2024199
Average age73
Average risk score2.19
Also on Medicaid9%

Dr. Kunk's Medicare patients by age, 2024

Dr. Kunk's Medicare patients by sex, 2024

  • Women8945%
  • Men11055%

Chronic conditions among Dr. Kunk's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol67%
  3. Cancer48%
  4. Arthritis41%
  5. Diabetes36%
  6. Ischemic heart disease28%
  7. Chronic kidney disease27%
  8. Anxiety25%

Share of Medicare patients with each condition. A patient can have several.

Dr. Kunk's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women46%
  • Men54%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Paul R. Kunk wrote 529 Medicare Part D claims in 2024

In 2024, Dr. Kunk wrote 529 Medicare Part D claims for 95 patients. 82% of them were for generic drugs. CMS names the drug for 345 of them, across 10 drugs with 11 or more claims each, at $86,060 in total drug cost. In 2023, CMS named 184 claims across 10 drugs.

Part D claims, 2024529
Drugs named by CMS10
Total drug cost$86,060
Part D patients95

Dr. Kunk's Part D claims by kind of drug, 2024

  • Generic432 claims82%
  • Brand-name97 claims18%

Dr. Kunk's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Kunk's Part D claims, 2024

  • Opioids8%44 of 529 claims
  • Antibiotics3%17 of 529 claims
  • Antipsychotics, patients 65 and over8%44 of 529 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1842024: 34588%

Drugs named by CMS: 10 in 2024, 10 in 2023.

See all prescribing by Dr. Kunk

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Paul R. Kunk scored 86 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Kunk for performance year 2024, reported as part of a group. Dr. Kunk accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kunk as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Kunk's MIPS scores, performance year 2024

  • 86of 100Final score
  • 79.8of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 75of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Kunk by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Paul R. Kunk has 17 publications on record

Dmand AI links 17 papers to Dr. Kunk, published from 2015 to 2025. 2016 was the busiest year, with 3. The most frequent topics are Antibodies, Monoclonal, Humanized, Anticoagulants and Antineoplastic Combined Chemotherapy Protocols. Dr. Kunk has published most often in J Immunother Cancer. Dr. Kunk's most frequent co-authors are Osama E. Rahma, MD, Craig L. Slingluff, MD and Todd W. Bauer, MD.

Papers17
Years published2015 to 2025

Dr. Kunk's papers by year, 2015 to 2025

Topics Dr. Kunk writes about most

  • Antibodies, Monoclonal, Humanized
  • Anticoagulants
  • Antineoplastic Combined Chemotherapy Protocols
  • B7-H1 Antigen
  • Bile Duct Neoplasms
  • Cholangiocarcinoma
  • Hemorrhage
  • Piperidines

Dr. Kunk's most frequent co-authors

Recent publications by Dr. Kunk

See all 17 publications and co-authors

See who Dr. Kunk researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kunk works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Paul R. Kunk has worked on 4 clinical trials

Dmand AI links Dr. Kunk to 4 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Gallbladder Neoplasms, Gallbladder Diseases and Pancreatic Neoplasms. National Cancer Institute (NCI) sponsors the most, 2.

Clinical trials with Dr. Kunk by phase

  1. NonePhase 1: no trials
  2. 2Phase 2: 2 trials
  3. 2Phase 3: 2 trials
  4. NonePhase 4: no trials

Conditions in Dr. Kunk's trials

  • Gallbladder Neoplasms
  • Gallbladder Diseases
  • Pancreatic Neoplasms
  • Pancreatic Diseases

Investigators on the most trials with Dr. Kunk

Recent clinical trials with Dr. Kunk

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Paul R. Kunk received $8,578 in industry payments from 2018 to 2025

CMS Open Payments shows 14 general payments to Dr. Kunk from 6 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. Exelixis Inc. paid the most, $5,466. It also lists 2 research payments totaling $6,400 from 2021 to 2022.

General payments to Dr. Kunk by program year, 2018 to 2025

General payments to Dr. Kunk by kind, 2018 to 2025

$8.6Kin total
  • Speaker and faculty fees$5,82068%
  • Travel and lodging$2,05524%
  • Food and beverage$7038%

Companies that paid Dr. Kunk the most, 2018 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Kunk

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Paul R. Kunk's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Paul R. Kunk

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Paul R. Kunk's NPI number?

Dr. Paul R. Kunk's NPI number is 1750671756. It was assigned on April 11, 2011, and it is active in the NPI Registry.

What kind of doctor is Dr. Paul R. Kunk?

Dr. Paul R. Kunk is a medical oncologist in Charlottesville, Virginia. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Paul R. Kunk practice?

Dr. Kunk practices at 1240 Lee St,, Charlottesville, VA 22903. Dr. Kunk's primary practice is Emily Couric Clinical Cancer Center in Charlottesville, Virginia. Dmand AI also links Dr. Kunk to 3 hospitals and 1 group practice or clinic.

What is Dr. Paul R. Kunk's office phone number?

The practice phone on file for Dr. Kunk is (434) 243-4704.

What is Dr. Paul R. Kunk's medical license number?

Dr. Kunk holds Virginia license 0101258510.

Which hospitals is Dr. Paul R. Kunk affiliated with?

Dr. Kunk is affiliated with University Medical Center. Dmand AI links Dr. Kunk to 3 more hospitals.

What medical group is Dr. Paul R. Kunk part of?

Dr. Kunk is linked to UVA Physicians Group.

Does Dr. Paul R. Kunk accept Medicare?

Yes. CMS data shows Dr. Kunk billed Medicare for 877 services in 2024, and Dr. Kunk accepts Medicare assignment.

Does Dr. Paul R. Kunk offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Kunk as offering telehealth services.

What is Dr. Paul R. Kunk's MIPS score?

Dr. Kunk's MIPS final score for performance year 2024 is 86 out of 100, reported as part of a group.

Show 7 more questionsShow fewer questions

How many Medicare patients does Dr. Paul R. Kunk see?

CMS counts 199 Medicare patients who saw Dr. Kunk in 2024, with an average age of 73.

What services does Dr. Paul R. Kunk bill to Medicare?

In 2024, Dr. Kunk's most billed Medicare services were medicare service (G2211), office visit, established patient (99215) and office visit, established patient (99214).

What drugs does Dr. Paul R. Kunk prescribe most?

In 2024 Medicare Part D data, Dr. Kunk's most prescribed drugs by claims were Prochlorperazine Maleate, Ondansetron HCl and Olanzapine.

Has Dr. Paul R. Kunk received payments from drug or device companies?

CMS Open Payments shows $8,578 in general payments to Dr. Kunk from 6 companies from 2018 to 2025. The largest total came from Exelixis Inc.

How long has Dr. Paul R. Kunk been practicing?

Dr. Kunk graduated from medical school in 2011, 15 years ago.

Does Dr. Paul R. Kunk do research?

Dmand AI links 17 publications to Dr. Kunk, published from 2015 to 2025. Dr. Kunk has worked on 4 clinical trials.

Who does Dr. Paul R. Kunk publish with?

Dr. Kunk's most frequent co-authors are Osama E. Rahma, MD (6 shared papers), Craig L. Slingluff, MD (5 shared papers) and Todd W. Bauer, MD (4 shared papers).

Selling to medical oncology practices?

See medical oncologists in Virginia by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)